Healthcare & Medical Investment (TSE:3455) EBIT: 円2,507 Mil (TTM As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3455 Healthcare & Medical Investment Corp TSE:3455
59 GF Score
Price 円105,400.00
GF Value 円129,254.71
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Healthcare & Medical Investment EBIT?

Healthcare & Medical Investment TSE:3455 -2.04% 59 EBIT is 円2,507 Mil as of Jan. 2026. GuruFocus rates TSE:3455 with a GF Score™ of 59/100 and a GF Value™ of 円129,254.71 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Healthcare & Medical Investment's earnings before interest and taxes (EBIT) for the six months ended in Jan. 2026 was 円1,284 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2026 was 円2,507 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Healthcare & Medical Investment's annualized ROC % for the quarter that ended in Jan. 2026 was 2.90%. Healthcare & Medical Investment's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2026 was 3.11%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Healthcare & Medical Investment's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2026 was 3.06%.

Healthcare & Medical Investment  (TSE:3455) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Healthcare & Medical Investment's annualized ROC % for the quarter that ended in Jan. 2026 is calculated as:

ROC % (Q: Jan. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jul. 2025 ) + Invested Capital (Q: Jan. 2026 ))/ count )
=2677.752 * ( 1 - 0.08% )/( (89962.829 + 94251.808)/ 2 )
=2675.6097984/92107.3185
=2.90 %

where

Invested Capital(Q: Jul. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=84495.86 - 134.438 - ( 2343.523 - max(0, 8404.573 - 2803.166+2343.523))
=89962.829

Invested Capital(Q: Jan. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=88786.067 - 160.833 - ( 2524.496 - max(0, 8759.266 - 3132.692+2524.496))
=94251.808

Note: The Operating Income data used here is two times the semi-annual (Jan. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Healthcare & Medical Investment's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jan. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jul. 2025  Q: Jan. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2567.876/( ( (80675.166 + max(-374.93, 0)) + (84264.968 + max(-281.07, 0)) )/ 2 )
=2567.876/( ( 80675.166 + 84264.968 )/ 2 )
=2567.876/82470.067
=3.11 %

where Working Capital is:

Working Capital(Q: Jul. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(45.254 + 0 + 414.389) - (134.438 + 0 + 700.135)
=-374.93

Working Capital(Q: Jan. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(46.654 + 0 + 561.542) - (160.833 + 0 + 728.433)
=-281.07

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jan. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Healthcare & Medical Investment's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jan. 2026 )
=2507.375/81936.804
=3.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthcare & Medical Investment EBIT Related Terms

Healthcare & Medical Investment EBIT Historical Data

* Premium members only.

The historical data trend for Healthcare & Medical Investment's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthcare & Medical Investment EBIT Chart

Healthcare & Medical Investment Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,023.20 2,212.59 2,593.88 2,417.91 2,427.68

Healthcare & Medical Investment Semi-Annual Data
Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,189.23 1,228.68 1,204.24 1,223.44 1,283.94

TSE:3455 vs WELL, VTR, OHI: EBIT Comparison

For the REIT - Healthcare Facilities subindustry, Healthcare & Medical Investment's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Healthcare & Medical Investment EV-to-EBIT vs REITs Industry

For the REITs industry and Real Estate sector, Healthcare & Medical Investment's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Healthcare & Medical Investment's EV-to-EBIT falls into.


TSE:3455
59GF Score
Healthcare & Medical Investment Corp TSE:3455
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healthcare & Medical Investment EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jan. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円2,507 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円2,507 Mil mean?
Healthcare & Medical Investment (TSE:3455) has a EBIT of 円2,507 Mil as of Jan. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Healthcare & Medical Investment.
Is Healthcare & Medical Investment's EBIT too high?
Healthcare & Medical Investment's current EBIT is 円2,507 Mil. Overall, Healthcare & Medical Investment has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthcare & Medical Investment's EBIT compare to WELL and VTR?
Healthcare & Medical Investment's EBIT of 円2,507 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a REITs company?
A good EBIT depends on the REITs industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Healthcare & Medical Investment. Healthcare & Medical Investment's current EBIT is 円2,507 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare & Medical Investment stock overvalued right now?
Based on GuruFocus' analysis, Healthcare & Medical Investment (TSE:3455) is currently considered Modestly Undervalued. The stock's GF Value™ is 円129,254.71, compared to a current price of 円105,400.00 — trading 18.5% below its estimated fair value. The current EBIT is 円2,507 Mil. Healthcare & Medical Investment's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Healthcare & Medical Investment (TSE:3455), the current EBIT is 円2,507 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healthcare & Medical Investment (TSE:3455) Overvalued in 2026?

Based on GuruFocus' analysis, Healthcare & Medical Investment stock appears to be undervalued. The current stock price of 円105,400.00 is trading 18.5% below its estimated GF Value™ of 円129,254.71. GuruFocus considers Healthcare & Medical Investment to be Modestly Undervalued.

Key valuation signals for TSE:3455:

  • EBIT: 円2,507 Mil
  • GF Value™: 円129,254.71 vs. price of 円105,400.00 (18.5% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the TSE:3455 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healthcare & Medical Investment Business Description

Industry Real EstateREITs
Address 3-3, Kanda-ogawamachi, Chiyoda-ku, Tokyo, JPN
Healthcare & Medical Investment Corp is an investment company, which invests in nursing homes facilities and medical related real properties. The company aims to achieve stable earnings from mid- to long-term perspectives through investment in real estate and other related assets. The firm primarily invests in facilities and buildings for the elderly, as well as medical related facilities.
59GF Score

Get the complete analysis for TSE:3455

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円105,400.00
Price
円129,254.71
GF Value